Company Overview of Macleod Pharmaceuticals, Inc.
As of October 1, 2012, Macleod Pharmaceuticals, Inc. was acquired by Neogen Corp. Macleod Pharmaceuticals, Inc. engages in the research, development, and manufacture of UNIPRIM oral equine antibiotic powder and Apple UNIPRIM flavored oral equine antibiotic powder. It also markets INTRACELL hydrophilic wound dressing for various species. The company distributes its products through distributors in the United States and Canada. The company was founded in 1989 and is based in Fort Collins, Colorado.
2600 Canton Court
Fort Collins, CO 80525
Founded in 1989
Key Executives for Macleod Pharmaceuticals, Inc.
Macleod Pharmaceuticals, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Praetego, Inc.||United States|
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Macleod Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.